During the past decade, Michigan Kidney Consultants conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Michigan Kidney Consultants" #1 collaborator was "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Michigan Kidney Consultants" are "ADPKD" (1 trials), "Anemia of Chronic Kidney Disease" (1 trials), "Autosomal Dominant Polycystic Kidney" (1 trials), "Calcific Uremic Arteriolopathy" (1 trials) and "Calciphylaxis" (1 trials). Many other conditions were trialed in "Michigan Kidney Consultants" in a lesser frequency.

Most popular intervention types in "Michigan Kidney Consultants" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Bardoxolone methyl oral capsule" (1 trials), "Experimatenl SNF472 (Open-label)" (1 trials), "Experimental: SNF472" (1 trials) and "Lesinurad" (1 trials). Other intervention names were less common.

The vast majority of trials in "Michigan Kidney Consultants" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Michigan Kidney Consultants". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Michigan Kidney Consultants, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Michigan Kidney Consultants, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".